Canada markets closed

Context Therapeutics Inc. (6K9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.3000+0.1800 (+16.07%)
At close: 04:51PM CET
Currency in EUR

Valuation Measures4

Market Cap (intraday) 20.48M
Enterprise Value -2.72M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.63
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 2.13
52-Week Change 3131.17%
S&P500 52-Week Change 327.86%
52 Week High 31.4400
52 Week Low 30.4200
50-Day Moving Average 30.9737
200-Day Moving Average 30.9895

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 515.97M
Implied Shares Outstanding 616.71M
Float 813.89M
% Held by Insiders 16.86%
% Held by Institutions 130.06%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-58.01%
Return on Equity (ttm)-102.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.06M
Net Income Avi to Common (ttm)-23.96M
Diluted EPS (ttm)-1.3800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.45M
Total Cash Per Share (mrq)0.9
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.83
Book Value Per Share (mrq)0.74

Cash Flow Statement

Operating Cash Flow (ttm)-21.05M
Levered Free Cash Flow (ttm)-12.78M